Viewing Study NCT00163254



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00163254
Status: UNKNOWN
Last Update Posted: 2006-09-12
First Post: 2005-09-08

Brief Title: Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee
Sponsor: University Hospital Tuebingen
Organization: University Hospital Tuebingen

Study Overview

Official Title: Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee
Status: UNKNOWN
Status Verified Date: 2006-09
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Below-Study is a randomized prospective mono-centre trial on the efficacy and safety the adjunctive use of a GP IIbIIIa antagonist for prevention of early reocclusion in arterial below-the knee interventions
Detailed Description: PTA below the knee is limited due to subacute reocclusions and uncertain long-term results This study is designed as a feasibility trial which compares the two new treatment modalities drug eluting stents and GP IIbIIIa blockade

Patients with current ulcers Rutherford 5 or 6 are randomly assigned to one of the treatment groups 1 ReoPro Sirolimus coated stent 2 ReoPro bare Stent 3 ReoPro PTA 4 PTA without ReoPro Angiographic control will be at 2 and 6 months with block wise randomisation to the treatment groups

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
D 3008290 None None None